investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Stromal activation in the progression of high ErbB2/1433zeta DCIS to IBC
Dihua Yu
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Dihua Yu
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
Denisa D Wagner
NETS in thrombosis and inflammatory responses
Breast
Philip Tofilon
Radiation-induced translational control of gene expression
Breast
Radiation Oncology
Powel Brown
ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER: A RANDOMIZED PRESURGICAL TRIAL
Breast
Ramesh K Ganju
Role of S100A7 in Breast Cancer Progression and Metastasis
Breast
Claudia Palena
Novel Targets for Vaccine Therapy
Breast
Tiffany Y Hsu
Elucidating the functions of Bud31, an essential gene in Myc-driven breast cancer
Breast
Jose Baselga
Unraveling resistance to PI3K-alpha inhibitors in breast cancer
Breast
Susan L Mooberry
Taccalonolides: Mechanisms of Action and Cellular Resistance
Breast
Dimitar B Nikolov
Function-blocking anti-ADAM protease antibodies for inhibition of tumorigenesis - NY
Breast